Quarterly report pursuant to Section 13 or 15(d)

Benefit Plans (Tables)

v3.22.1
Benefit Plans (Tables)
 3 Months Ended
Mar. 31, 2022
Retirement Benefits [Abstract]  
Schedule of Fair Value of Options Granted
The following table summarizes the weighted-average assumptions used to compute the fair value of options granted to employees, members of our board of directors and non-employees:
  For the Three Months Ended March 31,
  2022 2021
Risk-free interest rate 1.4% 0.6%
Expected life of options — years 3.60 6.10
Expected stock price volatility 32% 33%
Expected dividend yield 1.3% 1.0%
Schedule of Stock Options Activity Under Share-based Payment Plans
The following table summarizes stock option activity under our share-based plans for the three months ended March 31, 2022:
  Options
Weighted-Average
Exercise Price
Per Share (1)
Weighted-Average
Remaining
Contractual Term (Years)		 Aggregate
Intrinsic
Value
Outstanding as of December 31, 2021 161  $ 5.23 
Granted 9  $ 6.44 
Exercised (8) $ 4.60 
Forfeited, cancelled or expired (1) $ 6.28 
Outstanding as of March 31, 2022 161  $ 5.33  5.76 $ 210 
Exercisable as of March 31, 2022 100  $ 4.88  4.88 $ 176 
(1) The weighted-average exercise price for options outstanding and exercisable as of December 31, 2021 and March 31, 2022 in the table above have been adjusted to reflect the reduction of $0.25 to the exercise price related to the February 25, 2022 special cash dividend.
Schedule of Restricted Stock Unit and Stock Award Activity
The following table summarizes the restricted stock unit, including PRSU, activity under our share-based plans for the three months ended March 31, 2022:
  Shares Grant Date
Fair Value Per Share
Nonvested as of December 31, 2021 80  $ 6.22 
Granted 12  $ 6.93 
Vested (7) $ 6.06 
Forfeited (2) $ 6.31 
Nonvested as of March 31, 2022 83  $ 6.31